Amyloidosis
Risk Factors, Treatment Options & Clinical Aspects
Seiten
2016
Nova Science Publishers Inc (Verlag)
978-1-63485-884-7 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63485-884-7 (ISBN)
Amyloidosis is a result of the abnormal deposition of amyloid resulting in the disruption of organ and tissue function, which can be localised or systemic, with the kidney being most frequently affected. This book discusses the risk factors, treatment options and clinical aspects of amyloidosis. Chapter One explores amyloid cardiomyopathy. Chapter Two summarises current investigations utilising RNAi and immunotherapy to target the amyloid protein itself. Chapter Three reviews genetic counseling as an important component of the treatment algorithm for amyloidosis. Chapter Four discusses tissue examination in a diagnostic procedure. Chapter Five reviews protein studies in light-chain amyloidosis.
For Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php?products_id=59477
Erscheinungsdatum | 03.12.2016 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 155 x 230 mm |
Gewicht | 226 g |
Themenwelt | Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie |
ISBN-10 | 1-63485-884-0 / 1634858840 |
ISBN-13 | 978-1-63485-884-7 / 9781634858847 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich